Randomised comparison of anticoagulation control and monitoring with versus without laboratory-provided computerized decision support

Completed

• Conditions: Various; Circulatory System; Anticoagulation

• Registration Number: ISRCTN27244875
• Lead Sponsor: Ontario Program for Optimal Therapeutics (Canada)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-11-25
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 380

Inclusion Criteria

Physicians:
1. Family or general practitioner
2. Full-time office practice
3. Practice address within study laboratory catchment area
4. At least 3 eligible patients willing to participate

Patients:
1. On long-term warfarin therapy
2. Using the study laboratory for international normalized ratio (INR) tests and expecting to continue to do so for at least 12 months

Exclusion Criteria

None

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Acceptability of the CDS service, as assessed by the proportion of physicians who would continue to use it if offered<br>2. Estimated effectiveness, as assessed by percentage of time within target INR range

Secondary Outcome Measures

Name	Time	Method
Hemorrhagic and thromboembolic events requiring hospital attendance